Freiburg, Germany

Ulrich Posanski


Average Co-Inventor Count = 2.7

ph-index = 13

Forward Citations = 983(Granted Patents)


Company Filing History:


Years Active: 1986-2009

Loading Chart...
19 patents (USPTO):Explore Patents

Title: Ulrich Posanski: Innovator in Pharmaceutical Compositions

Introduction

Ulrich Posanski, based in Freiburg, Germany, is a distinguished inventor known for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 19 patents, Posanski has focused his efforts primarily on developing advanced pharmaceutical compositions, particularly those incorporating cyclosporins, which are key ingredients in various medical treatments.

Latest Patents

Among Ulrich Posanski's latest innovations are two notable patents. The first is related to "Cyclosporin galenic forms," which details pharmaceutical compositions containing cyclosporin as an active ingredient, combined with fatty acid triglycerides, glycerol fatty acid partial esters, or propylene glycol. This patent emphasizes the inclusion of a tenside with a hydrophilic-lipophilic balance (HLB) of at least 10, aiming to enhance the formulation's efficacy.

The second patent, titled "Pharmaceutical compositions comprising cyclosporins," focuses on creating formulations with cyclosporins like Ciclosporin or [Nva]-Ciclosporin in a 'microemulsion pre-concentrate' and microemulsion form. This innovation includes specific hydrophilic components like Calkyl or tetrahydrofurfuryl di- or partial-ether of low molecular weight mono- or poly-oxy-alkane diols, such as Transcutol or Glycofurol. The compositions also suggest incorporating saccharide monoesters, enhancing the potential applications in topical and oral dosage forms.

Career Highlights

Throughout his career, Ulrich Posanski has made substantial strides in the pharmaceutical industry. He has held positions at major corporations, including Novartis AG and Novartis Corporation, where his research and development contributions significantly advanced the company's product line and technological capabilities in drug formulation.

Collaborations

Posanski has also collaborated closely with esteemed colleagues, notably Birgit Hauer and Armin Meinzer. Together, they have worked on various projects aimed at optimizing pharmaceutical compositions and ensuring the successful transition from research to practical applications in the healthcare field.

Conclusion

Ulrich Posanski's dedication to innovation in pharmaceutical formulations has positioned him as a leading inventor in this critical field. With 19 patents to his name, his work continues to influence the development of effective medical treatments, showcasing the vital intersection of science and healthcare through innovative pharmaceutical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…